IPO in U.S. Provides Additional Funding & Common Stock that Trades on Nasdaq. On November 14, 2024, Medicus Pharma Ltd. closed an IPO (Initial Public Offering) in the United States.Gross proceeds ...

Medicus Pharma (NASDAQ:MDCX) priced its public offering of 2.26M units, on a "best-efforts" basis, at a price of $3.10 per unit. Each unit consists of one common share of the company and one ...

Explore Medicus Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MDCX.

WEST CONSHOHOCKEN – Medicus Pharma Ltd. has agreed to acquire Antev Ltd., a British late clinical-stage drug development company. The two companies recently entered into a binding letter of ...

Medicus to acquire Antev and expand into urology with Teverelix while reporting positive data in its Phase 2 skin cancer trial for D-MNA.

Medicus Pharma (NASDAQ:MDCX) priced its public offering of 2.26M units, on a "best-efforts" basis, at a price of $3.10 per unit.Each unit consists of one common share of the company and one ...